BriaCell Therapeutics Corp. Warrant expiring 2031 (NASDAQ: BCTXL) last traded at $1.09, up 9.01% on the session. The quote above updates while this page is open; the figures below are drawn from BriaCell Therapeutics Corp. Warrant expiring 2031’s own filings and are restated only when a new one is published.
BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) company overview
BriaCell Therapeutics Corp. Warrant expiring 2031 trades on NASDAQ under the ticker BCTXL. Its market capitalisation is $9.48 million.
BCTXL valuation
Valuation measures for BriaCell Therapeutics Corp. Warrant expiring 2031, derived from the latest quote and its most recent SEC filing.
Market cap
$9.48M
BCTXL financials
Trailing-twelve-month figures tagged in BriaCell Therapeutics Corp. Warrant expiring 2031's XBRL filings with the SEC.
Net income (TTM)
-$30.68M
Cash
$6.88M
BCTXL trading statistics
Range and volume for BCTXL over the past 52 weeks.
BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) last traded at $1.09, up 9.01% on the session. FurlPay quotes BCTXL from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is BCTXL listed on?
BriaCell Therapeutics Corp. Warrant expiring 2031 is listed on NASDAQ under the ticker symbol BCTXL.
What is BriaCell Therapeutics Corp. Warrant expiring 2031's market cap?
BriaCell Therapeutics Corp. Warrant expiring 2031 has a market capitalisation of $9.48 million, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is BCTXL's 52-week range?
Over the past 52 weeks BCTXL has traded between $0.99 and $1.11.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0001610820), period ending 2026-04-30.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.